Medix Inc
Medix Inc is an advertising and marketing company that generates revenue through services in the advertising and marketing industry.
Business. Medix Inc (331A.T) is a Japanese advertising and marketing company headquartered in Japan. The firm operates within the Cyclical Consumer Services sector, providing advertising and marketing solutions. Medix is primarily listed on the Tokyo Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Medix Inc (331A.T) is a Japanese advertising and marketing company headquartered in Japan. The firm operates within the Cyclical Consumer Services sector, providing advertising and marketing solutions. Medix is primarily listed on the Tokyo Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.
Medix Inc has a market capitalization of ¥3.64 billion, calculated from a market price of ¥480 per share and 7.58 million shares outstanding. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
The company's profitability and returns are not available for comparison to industry benchmarks due to the lack of disclosed financial metrics such as return on invested capital (ROIC) or operating margins. Without these metrics, it is not possible to determine whether Medix Inc is outperforming or underperforming its peers in the advertising and marketing industry.
Medix Inc's revenue concentration and geographic exposure are not disclosed in the available data. The company does not provide segment or geographic breakdowns in the source documents, making it difficult to assess the diversification of its revenue streams.
The company's growth trajectory is not quantifiable at this time. No revenue history or outlook data is available to determine whether Medix Inc is experiencing growth or contraction in the current or next fiscal year.
The company's risk profile is limited to the observation that liquidity risk could not be assessed. No further risk factors are disclosed in the source documents. The dilution risk is classified as low, with no specific sources or expected timeframe for potential dilution.
No recent events, such as filings or transcripts, are available in the source documents to provide insight into the company's recent operations or strategic direction.
- Medix Inc operates in the advertising and marketing industry with a market capitalization of ¥3.64 billion.
- The company's liquidity risk could not be assessed due to the lack of balance-sheet inputs and no going-concern language in source documents.
- Profitability and returns metrics are not available for comparison to industry benchmarks.
- Revenue concentration and geographic exposure are not disclosed in the available data.
- Growth trajectory and risk factors beyond liquidity are not quantifiable due to limited data availability.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Medix Inc Market data — financials · 2026-05-26